Cargando…
PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab
Differentiating inflammatory bowel disease (IBD) from other inflammatory diseases is often challenging. Programmed cell death protein-1 (PD-1) is expressed in T cells and is an indicator of their exhaustion. The role of PD-1 expression in diagnosing IBD and predicting the response of biologic agents...
Autores principales: | Kim, Min Kyu, Jo, Su In, Kim, Sang-Yeob, Lim, Hyun, Kang, Ho Suk, Moon, Sung‑Hoon, Ye, Byong Duk, Soh, Jae Seung, Hwang, Sung Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694145/ https://www.ncbi.nlm.nih.gov/pubmed/38044341 http://dx.doi.org/10.1038/s41598-023-48651-y |
Ejemplares similares
-
The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
por: Choi, Myeong Geun, et al.
Publicado: (2022) -
The real-world outcomes of vedolizumab in patients with ulcerative
colitis in Korea: a multicenter retrospective study
por: Ye, Byong Duk, et al.
Publicado: (2021) -
Immunoprofiling of Colitis-associated and Sporadic Colorectal Cancer and its Clinical Significance
por: Soh, Jae Seung, et al.
Publicado: (2019) -
Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
por: Hong, Hee Seung, et al.
Publicado: (2022) -
Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn’s Disease, Intestinal Tuberculosis, and Behcet’s Disease
por: Yoo, Ji Won, et al.
Publicado: (2023)